Impact of the IMPACT Trial
- PMID: 30584585
- PMCID: PMC6296790
- DOI: 10.15326/jcopdf.5.3.2018.0150
Impact of the IMPACT Trial
Comment on
- Once-Daily Single-Inhaler Triple Versus Dual Therapy in Patients with COPD
- Single-inhaler Triple Therapy in Symptomatic COPD Patients: FULFIL Subgroup Analyses
- Intensified Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial
- Corticosteroid Suppression of Antiviral Immunity Increases Bacterial Loads and Mucus Production in COPD Exacerbations
- Role of Eosinophils in Airway Inflammation of Chronic Obstructive Pulmonary Disease
Similar articles
-
A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design.AIDS. 1995 Aug;9(8):919-26. doi: 10.1097/00002030-199508000-00014. AIDS. 1995. PMID: 7576328 Clinical Trial.
-
Publication bias in the anesthesiology literature.Anesth Analg. 2012 May;114(5):1042-8. doi: 10.1213/ANE.0b013e3182468fc6. Epub 2012 Feb 17. Anesth Analg. 2012. PMID: 22344237
-
Determining the Impact of a School-Based Health Education Package for Prevention of Intestinal Worm Infections in the Philippines: Protocol for a Cluster Randomized Intervention Trial.JMIR Res Protoc. 2020 Jun 25;9(6):e18419. doi: 10.2196/18419. JMIR Res Protoc. 2020. PMID: 32584263 Free PMC article.
-
The cost-effectiveness of magnetic resonance imaging for investigation of the knee joint.Health Technol Assess. 2001;5(27):1-95. doi: 10.3310/hta5270. Health Technol Assess. 2001. PMID: 11532240 Review.
-
The Impact of Superfast Broadband, Tailored Booklets for Households, and Discussions With General Practitioners on Personal Electronic Health Readiness: Cluster Factorial Quasi-Randomized Control Trial.J Med Internet Res. 2019 Mar 11;21(3):e11386. doi: 10.2196/11386. J Med Internet Res. 2019. PMID: 30855234 Free PMC article. Clinical Trial.
References
-
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of COPD, 2018. GOLD website. http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revi... Published 2018 Accessed July 2018.
-
- Bremner PR,Birk R,Brealey N,Ismaila AS,Zhu C-Q,Lipson DA. Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study. Respir Res. 2018;19(1):19. doi: https://doi.org/10.1186/s12931-018-0724-0 - PMC - PubMed
-
- Wedzicha JA,Banerji D,Chapman KR,et al. (for the FLAME Investigators). Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med. 2016;374(23):2222-2234. doi: https://doi.org/10.1056/NEJMoa1516385 - PubMed
-
- Cazzola M,Ora J,Puxeddu E. Dual bronchodilation and exacerbations of COPD. J Thorac Dis. 2016;8(9):2383-2386. doi: https://doi.org/10.21037/jtd.2016.08.92 - PMC - PubMed
-
- Bourbeau J,Aaron SD,Barnes NC,Davis KJ,Lacasse Y,Nadeau G. Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: retrospective database studies have their limitations SA. Respir Med. 2017;123:94-97. doi: https://doi.org/10.1016/j.rmed.2016.12.015 - PubMed
LinkOut - more resources
Full Text Sources